The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.
The LIM-only protein FHL2, also known as DRAL or SLIM3, has a function in fine-tuning multiple physiological processes. FHL2 is expressed in the vessel wall in smooth muscle cells (SMCs) and endothelial cells and conflicting data have been reported on the regulatory function of FHL2 in SMC phenotype...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/26b213cef63945599aa7e3cec543a1a3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:26b213cef63945599aa7e3cec543a1a3 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:26b213cef63945599aa7e3cec543a1a32021-11-18T08:23:10ZThe LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.1932-620310.1371/journal.pone.0094931https://doaj.org/article/26b213cef63945599aa7e3cec543a1a32014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736599/?tool=EBIhttps://doaj.org/toc/1932-6203The LIM-only protein FHL2, also known as DRAL or SLIM3, has a function in fine-tuning multiple physiological processes. FHL2 is expressed in the vessel wall in smooth muscle cells (SMCs) and endothelial cells and conflicting data have been reported on the regulatory function of FHL2 in SMC phenotype transition. At present the function of FHL2 in SMCs in vascular injury is unknown. Therefore, we studied the role of FHL2 in SMC-rich lesion formation. In response to carotid artery ligation FHL2-deficient (FHL2-KO) mice showed accelerated lesion formation with enhanced Ki67 expression compared with wild-type (WT)-mice. Consistent with these findings, cultured SMCs from FHL2-KO mice showed increased proliferation through enhanced phosphorylation of extracellular-regulated kinase-1/2 (ERK1/2) and induction of CyclinD1 expression. Overexpression of FHL2 in SMCs inhibited CyclinD1 expression and CyclinD1-knockdown blocked the enhanced proliferation of FHL2-KO SMCs. We also observed increased CyclinD1 promoter activity in FHL2-KO SMCs, which was reduced upon ERK1/2 inhibition. Furthermore, FHL2-KO SMCs showed enhanced migration compared with WT SMCs. In conclusion, FHL2 deficiency in mice results in exacerbated SMC-rich lesion formation involving increased proliferation and migration of SMCs via enhanced activation of the ERK1/2-CyclinD1 signaling pathway.Kondababu KurakulaMariska VosIker Otermin RubioGoran MarinkovićReinhard BuettnerLukas C HeukampJan StapVivian de WaardClaudia M van TielCarlie J M de VriesPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e94931 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Kondababu Kurakula Mariska Vos Iker Otermin Rubio Goran Marinković Reinhard Buettner Lukas C Heukamp Jan Stap Vivian de Waard Claudia M van Tiel Carlie J M de Vries The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| description |
The LIM-only protein FHL2, also known as DRAL or SLIM3, has a function in fine-tuning multiple physiological processes. FHL2 is expressed in the vessel wall in smooth muscle cells (SMCs) and endothelial cells and conflicting data have been reported on the regulatory function of FHL2 in SMC phenotype transition. At present the function of FHL2 in SMCs in vascular injury is unknown. Therefore, we studied the role of FHL2 in SMC-rich lesion formation. In response to carotid artery ligation FHL2-deficient (FHL2-KO) mice showed accelerated lesion formation with enhanced Ki67 expression compared with wild-type (WT)-mice. Consistent with these findings, cultured SMCs from FHL2-KO mice showed increased proliferation through enhanced phosphorylation of extracellular-regulated kinase-1/2 (ERK1/2) and induction of CyclinD1 expression. Overexpression of FHL2 in SMCs inhibited CyclinD1 expression and CyclinD1-knockdown blocked the enhanced proliferation of FHL2-KO SMCs. We also observed increased CyclinD1 promoter activity in FHL2-KO SMCs, which was reduced upon ERK1/2 inhibition. Furthermore, FHL2-KO SMCs showed enhanced migration compared with WT SMCs. In conclusion, FHL2 deficiency in mice results in exacerbated SMC-rich lesion formation involving increased proliferation and migration of SMCs via enhanced activation of the ERK1/2-CyclinD1 signaling pathway. |
| format |
article |
| author |
Kondababu Kurakula Mariska Vos Iker Otermin Rubio Goran Marinković Reinhard Buettner Lukas C Heukamp Jan Stap Vivian de Waard Claudia M van Tiel Carlie J M de Vries |
| author_facet |
Kondababu Kurakula Mariska Vos Iker Otermin Rubio Goran Marinković Reinhard Buettner Lukas C Heukamp Jan Stap Vivian de Waard Claudia M van Tiel Carlie J M de Vries |
| author_sort |
Kondababu Kurakula |
| title |
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| title_short |
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| title_full |
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| title_fullStr |
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| title_full_unstemmed |
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| title_sort |
lim-only protein fhl2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/26b213cef63945599aa7e3cec543a1a3 |
| work_keys_str_mv |
AT kondababukurakula thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT mariskavos thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT ikeroterminrubio thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT goranmarinkovic thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT reinhardbuettner thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT lukascheukamp thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT janstap thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT viviandewaard thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT claudiamvantiel thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT carliejmdevries thelimonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT kondababukurakula limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT mariskavos limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT ikeroterminrubio limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT goranmarinkovic limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT reinhardbuettner limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT lukascheukamp limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT janstap limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT viviandewaard limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT claudiamvantiel limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells AT carliejmdevries limonlyproteinfhl2reducesvascularlesionformationinvolvinginhibitionofproliferationandmigrationofsmoothmusclecells |
| _version_ |
1718421849595969536 |